Martin Huber
Chief Executive Officer bij MERSANA THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Martin Huber
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
28
| Public Company | Pharmaceuticals: Major | 28 |
| Public Company | Pharmaceuticals: Major | 26 | |
24
| Subsidiary | Pharmaceuticals: Major | 24 |
| Public Company | Biotechnology | 22 | |
| Public Company | Biotechnology | 20 | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.
19
| Subsidiary | Pharmaceuticals: Major | 19 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Martin Huber via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Corporate Officer/Principal Private Equity Analyst Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director of Finance/CFO | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Director/Board Member Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HSBC HOLDINGS PLC | Major Banks | Director of Finance/CFO Director/Board Member | |
US Oncology, Inc.
 US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
US Oncology Holdings, Inc.
 US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services US Oncology Holdings, Inc. operates as a holding company, which offers medical oncology services, cancer center services, pharmaceutical services, and research services. The firm provides comprehensive practice management services for the non-clinical aspects of practice management to affiliated practices in its medical oncology and cancer center services segments. Its healthcare Informatics business collects and analyzes data to provide significant insight into drug performance and patient outcomes for ongoing product development and evaluation. The company was founded in March 2004 and is headquartered in The Woodlands, TX. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| OPTINOSE, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Chief Operating Officer General Counsel | |
The 100 Group
 The 100 Group Miscellaneous Commercial ServicesCommercial Services The 100 Group is an organization that represents the views of finance directors from FTSE 100 and several large UK private companies. The private company is based in London, UK. The group is structured through committees that meet quarterly to discuss emerging topics on the agenda of finance directors. The main objective of the 100 Group is to promote the competitiveness of businesses. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman Chairman | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer President | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | President Corporate Officer/Principal Sales & Marketing | |
| NUVALENT, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline Services Unlimited
 GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| BCLS ACQUISITION CORP. | Financial Conglomerates | Director of Finance/CFO Director/Board Member | |
Glaxo Group Ltd.
 Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The private company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aegle Therapeutics Corp.
 Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Biotechnology | Director/Board Member Chief Operating Officer |
Statistieken
Internationaal
| Verenigde Staten | 40 |
| Verenigd Koninkrijk | 8 |
| Duitsland | 2 |
| Zwitserland | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 9 |
| Finance | 5 |
| Health Services | 3 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 438 |
| Corporate Officer/Principal | 253 |
| Independent Dir/Board Member | 159 |
| Chairman | 94 |
| Undergraduate Degree | 76 |
Sterkste connecties
| Insiders | |
|---|---|
| Pierre Legault | 45 |
| David Mott | 45 |
| Michael Ross | 44 |
| Anjali Bansal | 37 |
| Daniel Lynch | 32 |
| Simon Dingemans | 31 |
| Lonnie Moulder | 31 |
| Kavita Patel | 30 |
| Dennis Podlesak | 27 |
| Briggs Morrison | 26 |
| Iain Mackay | 25 |
| Jonathan Symonds | 24 |
| Philip Hampton | 24 |
| Dave Grayzel | 23 |
| Andrew Hack | 20 |
- Beurs
- Insiders
- Martin Huber
- Bedrijfsconnecties
